Joyson Karakunnel
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Immunology top 10%
- Molecular Biology
- Cancer Research
- Co-authors
- Keith E. SteeleNaiyer A. RizviScott AntoniaAni Sarkis BalmanoukianSarah B. GoldbergRachel E. SanbornRajesh NarwalYu Gu
- Topics
- Cancer Immunotherapy and Biomarkers (20 papers)CAR-T cell therapy research (9 papers)Pancreatic and Hepatic Oncology Research (6 papers)
- Cited by
- OncologyImmunologyPhysiology
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
Joyson Karakunnel
37 papers receiving 1.0k citations
Hit Papers
Peers
Comparison fields: 5 of 68
- Oncology 855
- Pulmonary and Respiratory Medicine 418
- Immunology 293
- Molecular Biology 146
- Cancer Research 83
Countries citing papers authored by Joyson Karakunnel
This map shows the geographic impact of Joyson Karakunnel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joyson Karakunnel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joyson Karakunnel more than expected).
Fields of papers citing papers by Joyson Karakunnel
This network shows the impact of papers produced by Joyson Karakunnel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joyson Karakunnel. The network helps show where Joyson Karakunnel may publish in the future.
Co-authorship network of co-authors of Joyson Karakunnel
This figure shows the co-authorship network connecting the top 25 collaborators of Joyson Karakunnel. A scholar is included among the top collaborators of Joyson Karakunnel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joyson Karakunnel. Joyson Karakunnel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 30 | |
| 2 | 27 | |
| 3 | 2 | |
| 4 | 48 | |
| 5 | 30 | |
| 6 | 54 | |
| 7 | 1 | |
| 8 | 8 | |
| 9 | 7 | |
| 10 | 100 | |
| 11 | 1 | |
| 12 | Safety and antitumour activity of durvalumab plus tremelimumab in non-small cell lung cancer: a multicentre, phase 1b studybreakdown → | 481 |
| 13 | 18 | |
| 14 | 2 | |
| 15 | 3 | |
| 16 | 7 | |
| 17 | 36 | |
| 18 | 4 | |
| 19 | 1 | |
| 20 | 36 |
About Joyson Karakunnel
Joyson Karakunnel is a scholar working on Physiology, Oncology and Hepatology, having authored 39 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (20 papers), CAR-T cell therapy research (9 papers) and Pancreatic and Hepatic Oncology Research (6 papers). The work is most often cited by research in Oncology (855 citations), Immunology (293 citations) and Physiology (62 citations). Joyson Karakunnel has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Keith E. Steele, Naiyer A. Rizvi, Scott Antonia, Ani Sarkis Balmanoukian, Sarah B. Goldberg, Rachel E. Sanborn, Rajesh Narwal, Yu Gu, Jamie E. Chaft and Ashok Gupta. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.